Operating cash flow low at 31 million won, but ample liquidity: cash 8.5 billion won and short-term financial products 33.2 billion won, total over 50 billion won
Investment gains of 698 million won from financial asset disposals and valuation contributed to net profit (one-off)
R&D expenses 1.6 billion won (42.4% of revenue), maintaining high investment
Subsidiaries (Afreeca, BrainzLab) combined net loss of 146 million won, dragging consolidated earnings
Contingent liabilities: guarantee insurance 3.85 billion won; no pending litigation